You are here

Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Bipolar Affective Psychosis, Mania, Manic-Depressive Psychosis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Manic and mixed episodes of up to moderate severity in patients with Type I and II
bipolar disorder and schizoaffective disorder; either first diagnosed or repeated
episodes

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Hypersensitivity to ziprasidone

- prolonged QTc interval

- coadministration with substances that are prolonging the QTc interval

- recent acute MI, cardiac failure, patients with arrhythmias treated with class IA or
III medicaments

NCT00454883
Pfizer
Completed
Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now